3D Tissue Models

Oncology: Institut Pasteur

Total Score People Score Events Score
10 9 10
Date Event Presentation Speakers
September 12, 2013 The 2nd International Conference on Genomics in the Americas Day 1: Keynote Session: The State of the Genomics Industry Today Leroy E Hood
June 5, 2013 RNA Therapeutics Polyalkylcyanoacrylate and nanodiamond nanoparticles for the delivery of oligonucleotides targeting the EWS/Fli-1 oncogene associated to Ewing sarcoma Claude Paul Malvy
April 6, 2013 AACR Annual Meetings BRAF Pathway Inhibitors in Melanoma: Where Do We Go from Here? Chairperson: Richard M. Marais, Paterson Institute for Cancer Research, Manchester, United Kingdom Richard M Marais
July 6, 2011 3rd WIN Symposium Integrating pre-clinical models with clinical data - drivers and passengers Leroy E Hood
February 12, 2011 Cancer Control by Tumor Suppressors and Immune Effectors (J8) Dendritic Cells (J7) | Talk Title to be Determined Federica Sallusto
May 19, 2010 Towards Personalized Cancer Medicine Synthetic Lethal Approaches to Cancer Therapy Alan Ashworth
November 2, 2009 Track 1: Seventh Annual RNAi for Screening Cellular Pathways and Targets High-Throughput Biology Using RNAi arrays Neil Emans
February 19, 2008 Screening Europe Track B Phenotypic Cell-Based Assay Development for HTS for Anti-Infectious Diseases Drugs Identification Thierry Christophe
November 6, 2007 Chemotherapy Foundation Symposium XXV BORTEZOMIB & SM-153 LEXIDRONAM COMBINATION THERAPY IN MUTIPLE MYELOMA James R. Berenson
October 16, 2007 Inaugural HDAC inhibitors: Meeting the Challenges of Chemical Development of HDAC Inhibitors Oct (16 -17) NEXT GENERATION HDAC INHIBITORS (10:35-12:40) Andreas Schwienhorst
NEXT GENERATION HDAC INHIBITORS: Substrate and Inhibitor Specificities of HDACs Lessons to Learn From a Bacterial Class 2 Homologue (10:40-11:10) Andreas Schwienhorst
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.